H. Hasegawa et al. / Tetrahedron 59 (2003) 827–832
831
was added N-chlorosuccinimide (1.0 equiv.) under nitrogen
atmosphere at room temperature. After stirring for 30 min,
Bu3SnH (1.0 equiv.) and AIBN (0.2 equiv.) were added and
the solution was heated under reflux for 7 h. After
evaporation of toluene, the residue was diluted with 5 ml
of ethyl acetate and stirred vigorously with 10%-KF
aqueous solution for several hours to remove tin by-product.
The precipitate (Bu3SnF) was filtered off, and the aqueous
phase was made basic by 2N NaOH and was extracted
with Et2O. The combined organic layers were washed with
water and brine, and dried over MgSO4. After evaporation
of the solvent, the resultant crude product was purified with
TLC (Al2O3) to give 2-methylenepyrrolizidines 3a–f and
4a,b.
3.36 (1H, d, J¼9.9 Hz), 3.5–3.6 (2H, m), 3.89 (1H, dt,
J¼2.6, 17.2 Hz), 5.47 (1H, dd, J¼2.6, 5.3 Hz), 7.1–7.3 (5H,
m); 13C NMR dC 20.47 (CH3), 27.46 (CH2), 33.69 (CH2),
55.04 (CH2), 56.30 (CH), 60.16 (CH), 75.29 (CH), 111.91
(CH), 126.94 (CH), 128.50 [(CH)£2], 128.73 [(CH)£2],
140.32 (C), 149.76 (C); IR 1650, 1458, 1377, 700 cm21; MS
(EI) m/z 247 (Mþ, 72), 212 [(M2Cl)þ, 51], 129 (100%);
HRMS calcd for C15H18NCl: m/z 247.1128. Found: m/z
247.1164.
4.4.3. Radical cyclization of 2c; 1,5-diphenyl-2-methyl-
enepyrrolizidine (3c). Al2O3-TLC (hexaneþAcOEt (10:1),
Rf¼0.83); oil; 1H NMR dH 1.8–2.0 (2H, m), 2.16 (1H, m),
2.35 (1H, m), 3.4–3.6 (2H, m), 3.8–3.9 (3H, m), 4.61 (1H,
dd, J¼2.0, 4.3 Hz), 4.97 (1H, dd, J¼2.0, 4.3 Hz), 7.2–7.4
(10H, m); 13C NMR dC 29.15 (CH2), 36.39 (CH2), 57.25
(CH), 57.68 (CH2), 69.70 (CH), 74.12 (CH), 107.04 (CH2),
126.54 (CH), 126.97 (CH), 127.17 [(CH)£2], 128.37
[(CH)£2], 128.53 [(CH)£2], 128.73 [(CH)£2], 141.49 (C),
143.84 (C), 155.70 (C); IR 1458, 1378, 699 cm21; MS (EI)
m/z 275 (Mþ, 100%); HRMS calcd for C20H21N: m/z
275.1674. Found: m/z 275.1672.
4.4.1. Radical cyclization of 2a; 5-methyl-2-methylene-1-
propylpyrrolizidine (3a) and 2-chloromethylene-5-
methyl-1-propylpyrrolizidine (4a). Compound 3a.
Al2O3-TLC (hexaneþAcOEt (10:1), Rf¼0.44); oil; 1H
NMR dH 0.92 (3H, t, J¼6.9 Hz), 1.08 (3H, d, J¼6.3 Hz),
1.3–1.4 (3H, m), 1.5–1.6 (3H, m), 1.97 (1H, m), 2.1–2.2
(2H, m), 2.63 (1H, m), 3.26 (1H, m), 3.29 (1H, dt, J¼1.7,
14.8 Hz), 3.61 (1H, ddd, J¼1.7, 3.6, 14.8 Hz), 4.83 (1H,
ddd, J¼0.7, 2.0, 4.3 Hz), 4.89 (1H, dd, J¼2.0, 3.6 Hz); 13C
NMR dC 14.47 (CH3), 20.59 (CH3), 20.81 (CH2), 31.03
(CH2), 35.04 (CH2), 35.25 (CH2), 49.51 (CH), 57.25 (CH2),
60.66 (CH), 71.61 (CH), 104.24 (CH2), 155.00 (C); IR 1457,
1376 cm21; MS (EI) m/z 179 (Mþ, 44), 164 [(M2CH3)þ,
100], 150 [(M2C2H5)þ, 87], 136 [(M2C3H7)þ, 54%];
HRMS calcd for C12H21N: m/z 179.1674. Found: m/z
179.1681.
4.4.4. Radical cyclization of 2d; 1-triethylsilyl-5-methyl-
2-methylenepyrrolizidine (3d). Al2O3-TLC (hexaneþ
AcOEt (30:1), Rf¼0.44); oil; 1H NMR dH 0.61 (6H, q,
J¼7.6 Hz), 0.97 (9H, t, J¼7.6 Hz), 1.07 (3H, t, J¼5.9 Hz),
1.48 (2H, m), 1.81 (1H, m), 1.97 (1H, m), 2.17 (1H, m), 2.55
(1H, m), 3.31 (1H, d, J¼15.2 Hz), 3.47 (1H, dd, J¼2.3,
15.2 Hz), 3.70 (1H, dt, J¼3.0, 7.6 Hz), 4.74 (1H, s), 4.82
(1H, s); 13C NMR dC 2.32 [(CH2)£3], 7.60 [(CH3)£3],
20.20 (CH3), 31.81 (CH2), 34.09 (CH2), 38.11 (CH), 57.68
(CH), 58.38 (CH2), 67.69 (CH), 102.87 (CH2), 152.94 (C);
IR 1647, 1240, 867 cm21; MS (EI) m/z 251 (Mþ, 33.2), 236
(55.5), 222 (58.3), 136 (100%); HRMS calcd for
C15H29NSi: m/z 251.2069. Found: m/z 251.2061.
Compound 4a. Rf¼0.50; oil; 1H NMR dH 0.92 (3H, t,
J¼7.3 Hz), 1.10 (3H, d, J¼6.3 Hz), 1.2–1.4 (3H, m), 1.5–
1.6 (3H, m), 1.98 (1H, m), 2.12 (1H, m), 2.31 (1H, m), 2.61
(1H, m), 3.31 (1H, dt, J¼4.3, 7.6 Hz), 3.52 (1H, dd, J¼2.3,
16.8 Hz), 3.68 (1H, dt, J¼2.3, 16.8 Hz), 5.83 (1H, dd,
J¼2.3, 4.6 Hz); 13C NMR dC 14.38 (CH3), 20.56 (CH3),
20.59 (CH2), 30.17 (CH2), 34.45 (CH2), 35.56 (CH2), 49.38
(CH2), 54.64 (CH), 60.32 (CH), 72.18 (CH), 108.91 (CH),
148.82 (C); IR 1650, 1458, 1377, 734 cm21; MS (EI) m/z
213 (Mþ, 19), 198 [(M2CH3)þ, 32], 184 [(M2C2H5)þ, 36],
178 [(M2Cl)þ, 100%]; HRMS calcd for C12H20N: m/z
178.1596. Found: m/z 178.1612.
4.4.5. Radical cyclization of 2f; perhydro-2-methylene-1-
phenylpyrrolo[1,2-a]indole (3f). Al2O3-TLC (hexaneþ
1
AcOEt (10:1), Rf¼0.50); oil; H NMR dH 1.1–1.9 (10H,
m), 2.16 (1H, m), 2.89 (1H, d, J¼3.6 Hz), 3.34 (1H, d,
J¼9.6 Hz), 3.45 (1H, dd, J¼1.0, 14.8 Hz), 3.73 (1H, m),
3.86 (1H, d, J¼14.8 Hz), 4.50 (1H, d, J¼2.0 Hz), 4.97 (1H,
d, J¼2.0 Hz), 7.2–7.3 (5H, m); 13C NMR dC 20.58 (CH2),
24.69 (CH2), 27.82 (CH2), 28.79 (CH2), 36.89 (CH2), 39.73
(CH), 57.79 (CH), 57.92 (CH2), 64.85 (CH), 71.99 (CH),
106.34 (CH2), 127.39 (CH), 128.43 [(CH)£2], 128.82
[(CH)£2], 140.72 (C), 155.29 (C); IR 1659, 1454, 746,
700 cm21; MS (EI) m/z 253 (Mþ, 100), 210 (51), 129
(40%); HRMS calcd for C18H23N: m/z 253.1830. Found:
m/z 253.1834.
4.4.2. Radical cyclization of 2b; 5-methyl-2-methylene-1-
phenylpyrrolizidine (3b) and 2-chloromethylene-5-
methyl-1-phenylpyrrolizidine (4b). Compound 3b.
Al2O3-TLC (hexaneþAcOEt (4:1), Rf¼0.63); oil; 1H
NMR dH 1.14 (3H, d, J¼6.3 Hz), 1.5–1.7 (2H, m), 2.0–
2.1 (2H, m), 2.80 (1H, m), 3.33 (1H, d, J¼9.2 Hz), 3.54 (1H,
d, J¼15.5 Hz), 3.62 (1H, m), 3.85 (1H, dd, J¼1.7, 15.5 Hz),
4.58 (1H, d, J¼2.0 Hz), 5.00 (1H, d, J¼1.3 Hz), 7.2–7.3
(5H, m); 13C NMR dC 21.08 (CH3), 28.93 (CH2), 34.63
(CH2), 57.27 (CH), 57.77 (CH2), 61.01 (CH), 74.77 (CH),
107.24 (CH2), 126.88 (CH), 128.88 [(CH)£2], 129.13
[(CH)£2], 141.85 (C), 156.17 (C); IR 1661, 1454, 748,
700 cm21; MS (EI) m/z 213 (Mþ, 99.7), 198 [(M2CH3)þ,
100], 136 [(M2C6H5)þ, 11.0%]; HRMS calcd for C15H19N:
m/z 213.1517. Found: m/z 213.1531.
References
1. Reviews: (a) Jasperse, C. P.; Curran, D. P.; Fevig, T. L. Chem.
Rev. 1991, 91, 1237–1286. (b) Bunce, R. A. Tetrahedron
1995, 51, 13103–13159. (c) Parsons, P. J.; Penkett, C. S.;
Shell, A. J. Chem. Rev. 1996, 96, 195–206. (d) Malacria, M.
Chem. Rev. 1996, 96, 289–306. (e) Dhimane, A.-L.;
Fensterbank, L.; Malacria, M. In Polycyclic Compounds via
Radical Cascade Reactions. Radicals in Organic Synthesis;
Compound 4b. Rf¼0.55; oil; 1H NMR dH 1.10 (3H, d,
J¼5.9 Hz), 1.5–1.7 (2H, m), 1.9–2.1 (2H, m), 2.73 (1H, m),